推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

ACTA DIABETOLOGICA

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 ACTA DIABETOL最新评论:10-18投,10-21with editor,10-27状态不变,已拒; 10-22投,submitted to journal,10-24with editor,10-28under revi... (2024-10-24)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
 
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


ACTA DIABETOLOGICA期刊基本信息Hello,您是该期刊的第32535位访客


基本信息 登录收藏
期刊名字ACTA DIABETOLOGICAACTA DIABETOLOGICA

ACTA DIABETOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.5
53人评分
我要评分

声誉
7.5

影响力
5.2

速度
8.7

期刊ISSN0940-5429
微信扫码收藏此期刊
E-ISSN1432-5233
2023-2024最新影响因子
(数据来源于搜索引擎)
3.1 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:2.082
2023-2024自引率3.20%点击查看自引率趋势图
五年影响因子3.4
JCI期刊引文指标 0.85
h-index 56
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
7.300.9800.943
学科分区排名百分位
大类:Medicine
小类:Internal Medicine
Q131 / 167
大类:Medicine
小类:Endocrinology, Diabetes and Metabolism
Q161 / 244
大类:Medicine
小类:Endocrinology
Q240 / 128

期刊简介
Acta Diabetologica is a journal that publishes reports of experimental and clinical research on diabetes mellitus and related metabolic diseases. Original contributions on biochemical, physiological, pathophysiological and clinical aspects of research on diabetes and metabolic diseases are welcome. Reports are published in the form of original articles, short communications and letters to the editor. Invited reviews and editorials are also published. A Methodology forum, which publishes contributions on methodological aspects of diabetes in vivo and in vitro, is also available. The Editor-in-chief will be pleased to consider articles describing new techniques (e.g., new transplantation methods, metabolic models), of innovative importance in the field of diabetes/metabolism. Finally, workshop reports are also welcome in Acta Diabetologica.
期刊官方网站https://www.springer.com/592
期刊投稿网址https://www.editorialmanager.com/acdi/
作者指南网址https://www.springer.com/592/submission-guidelines
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足ACTA DIABETOLOGICA的语言要求,还能让ACTA DIABETOLOGICA编辑和审稿人得到更好的审稿体验,让稿件最大限度地被ACTA DIABETOLOGICA编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式SPRINGER, 233 SPRING ST, NEW YORK , USA, NY, 10013
出版商Springer Milan
涉及的研究方向医学-内分泌学与代谢
出版国家或地区ITALY
出版语言English
出版周期Quarterly
出版年份1964
年文章数 169点击查看年文章数趋势图
Gold OA文章占比39.24%
研究类文章占比:
文章 ÷(文章 + 综述)
89.94%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ENDOCRINOLOGY & METABOLISMSCIEQ285/186
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ENDOCRINOLOGY & METABOLISMSCIEQ266/186
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区3区2区
ENDOCRINOLOGY & METABOLISM
内分泌学与代谢
3区3区3区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区3区1区
ENDOCRINOLOGY & METABOLISM
内分泌学与代谢
2区2区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区3区2区
ENDOCRINOLOGY & METABOLISM
内分泌学与代谢
4区3区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0940-5429%5BISSN%5D
平均审稿速度网友分享经验:
平均2月
平均录用比例网友分享经验:
约50%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在ACTA DIABETOLOGICA顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 ACTA DIABETOLOGICA期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 ACTA DIABETOLOGICA中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
ACTA DIABETOLOGICA上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Nature Reviews Endocrinology11642.00
    Cell Metabolism21948.60
    ENDOCRINE REVIEWS25742.00
    DIABETES CARE32829.50
    TRENDS IN ENDOCRINOLOGY AND METABOLISM14620.10
    METABOLISM-CLINICAL AND EXPERIMENTAL12218.90
    Cardiovascular Diabetology6412.30
    DIABETOLOGIA20718.10
    JOURNAL OF PINEAL RESEARCH11317.70
    Obesity Reviews13719.30
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE677320
    BIOMATERIALS567016
    BIOMEDICINE & PHARMACOTHERAPY551721
    Frontiers in Pharmacology515525
    Journal of Materials Chemistry B506403
    Frontiers in Immunology492230
    COMPUTERS IN BIOLOGY AND MEDICINE474054
    JOURNAL OF ETHNOPHARMACOLOGY466427
    COLLOIDS AND SURFACES B-BIOINTERFACES438646
    Frontiers in Oncology436282
  •  

    ACTA DIABETOLOGICA ACTA DIABETOLOGICA
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.gamma-aminobutyric acid modulates alpha-cell hyperplasia but not beta-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice

    Author: Gu, Liangbiao; Cui, Xiaona; Lin, Xiafang; Yang, Jin; Wei, Rui; Hong, Tianpei; Yang, Kun
    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 1, pp. 19-28. DOI: 10.1007/s00592-022-01970-4
        PubMed      DOI
    2.Circ ASAP2 decreased inflammation and ferroptosis in diabetic nephropathy through SOX2/SLC7A11 by miR-770-5p

    Author: Li, Qin; Meng, Xiangjian; Hua, Qiang
    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 1, pp. 29-42. DOI: 10.1007/s00592-022-01961-5
        PubMed      DOI
    3.Development and validation of a model that predicts the risk of diabetic retinopathy in type 2 diabetes mellitus patients

    Author: Yang, Jing; Jiang, Sheng
    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 1, pp. 43-51. DOI: 10.1007/s00592-022-01973-1
        PubMed      DOI
    4.Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study

    Author: Zou, Yutong; Zhao, Lijun; Zhang, Junlin; Wang, Yiting; Wu, Yucheng; Ren, Honghong; Wang, Tingli; Zhao, Yuancheng; Xu, Huan; Li, Lin; Tong, Nanwei; Liu, Fang
    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 2, pp. 225-233. DOI: 10.1007/s00592-022-01978-w
        PubMed      DOI
    5.Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

    Author: Cao, Haiyan; Rao, Xiaosheng; Jia, Junya; Yan, Tiekun; Li, Dong
    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 3, pp. 325-335. DOI: 10.1007/s00592-022-01989-7
        PubMed      DOI
    6.Prognostic nutritional index as a risk factor for diabetic kidney disease and mortality in patients with type 2 diabetes mellitus

    Author: Zhang, Junlin; Chen, Yao; Zou, Liang; Gong, Rong
    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 2, pp. 235-245. DOI: 10.1007/s00592-022-01985-x
        PubMed      DOI
    7.Salivary telomere length and the risks of prediabetes and diabetes among middle-aged and older adults: findings from the Health and Retirement Study

    Author: Yu, Hong-jie; Ho, Mandy; Chau, Pui Hing; Geng, Leiluo; Fong, Daniel Yee Tak
    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 2, pp. 273-283. DOI: 10.1007/s00592-022-02004-9
        PubMed      DOI
    8.Single nucleotide polymorphisms in the GFR-related gene and the SNP-SNP interactions on the risk of diabetic kidney disease in Chinese Han population

    Author: Liu, Yanxiu; Chen, Yan; Yang, Qiwei; Shen, Dihan; Du, Zhenwu; Zhang, Guizhen
    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 1, pp. 115-125. DOI: 10.1007/s00592-022-01988-8
        PubMed      DOI
    9.The HIF1 alpha polymorphism rs2301104 is associated with obesity and obesity-related cytokines in Han Chinese population

    Author: Zheng, Xiaoya; Ma, Jiani; Long, Jian; Wei, Qiang; Ren, Wei
    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 2, pp. 285-292. DOI: 10.1007/s00592-022-02008-5
        PubMed      DOI
    10.Longitudinal changes in serum adropin levels and liver fat content during liraglutide treatment in newly diagnosed patients with type 2 diabetes mellitus and metabolic dysfunction-associated fatty liver disease

    Author: Zhang, Lin; Wu, Xiaojuan; Li, Xinyue; Chang, Xiaona; Ding, Xiaoyu; Wang, Qiu; Jiang, Tao; Wang, Guang; Liu, Jia
    Journal: ACTA DIABETOLOGICA. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00592-023-02082-3
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Computational Visual Media016.90
    Industrial and Organizational Psychology-Perspectives on Science and Practice07.70
    COMMUNICATIONS OF THE ACM18916.10
    MedComm06.70
    Journal of Econometrics1358.60
    CLINICAL NUCLEAR MEDICINE532.90
    Journal of International Financial Management & Accounting09.10
    BMJ Evidence-Based Medicine08.90
    ARCHIVOS DE BRONCONEUMOLOGIA413.50
    ARCHIVOS DE BRONCONEUMOLOGIA463.50
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共65


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室